510(k) device
t:slim Insulin Delivery System, t:flex Insulin Delivery System
Tandem Diabetes Care, Inc. · Pump, Infusion, Insulin (LZG, Class II) · First FDA decision Nov 9, 2011, newest Oct 25, 2016Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
510(k) pathway
Device trials
6
Naming "t slim"
MAUDE reports
1,261
Brand "t slim", since 2015
PubMed studies
15
Mentioning "t slim"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing t:slim Insulin Delivery System, t:flex Insulin Delivery System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
K162080 · Decided Oct 25, 2016 · 90 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Insulin Infusion PumpNational analysisReview closedCAG-00041NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "t slim", any status and sponsor, newest update first.
Castilla-La Mancha Health ServiceAcademic, hospital or other
NCT06834334 · 189 participants · Start Feb 27, 2025 · Primary completion Oct 1, 2025
Device: MM780G; TTSX2 and 1 more · For: Type 1 Diabetes (T1D)
Sites: Badajoz, Spain; Terrassa, Spain; Ciudad Real, Spain
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "t slim", and for the whole product code for context.
This brand
1,261 reports: 849 malfunction, 407 injury, 2 death
Whole product code LZG
385,399 reports: 329,529 malfunction, 55,119 injury, 355 death
Newest reports for this brand
MW6002288 · Received Sep 14, 2026 · Event dated May 5, 2026
Device type: Pump, Infusion, Insulin (LZG)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cancer
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0827-2014 · Started Jan 10, 2014 · Posted by FDA Feb 10, 2014
Reason given: Specific lots of insulin cartridges that are used with the T:slim Insulin Pump may be at risk for leaking. A cartridge leak could result in the device delivering too much or too little insulin, which can lead to a serious adverse event.
Cause as FDA categorized it: Equipment maintenance · Device type: Pump, Infusion, Insulin (LZG)
Published research
The most relevant PubMed records for "t slim"[tiab]. The summary above synthesizes these.
- Smartphone Bolus Feature Increases Number of Insulin Boluses in People With Low Bolus Frequency.
Messer LH, D'Souza E, Merchant G, et al. · J Diabetes Sci Technol · 2024
- Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology.
Shah VN, Akturk HK, Trahan A, et al. · J Diabetes Sci Technol · 2024
- Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial.
Carlson AL, Graham TE, Akturk HK, et al. · J Diabetes Sci Technol · 2024Multicenter Study, Clinical Trial
- Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes.
Piona C, Passanisi S, Bombaci B, et al. · Diabetes Obes Metab · 2024Letter
- Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review.
Mameli C, Smylie GM, Marigliano M, et al. · Diabetes Ther · 2024Review
- Real-World Glycemic and Person-Reported Outcomes After Tandem Control-IQ Initiation in Children With Type 1 Diabetes.
De Meulemeester J, Valgaerts L, Massa G, et al. · J Clin Endocrinol Metab · 2025Observational Study, Multicenter Study
- First Use of Control-IQ+ Technology in Newly Indicated Populations.
Assadi KZ, D'Souza EW, Pinsker JE, et al. · Diabetes Technol Ther · 2026
- Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes.
De Meulemeester J, Fiorentino F, Picado N, et al. · Diabetes Technol Ther · 2026Multicenter Study
- An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy.
Sawyer A, Forlenza GP, Wadwa RP · Expert Rev Med Devices · 2025Review
- Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes.
Singh LG, Lum JW, Kanapka L, et al. · Diabetes Technol Ther · 2026Randomized Controlled Trial
- One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study.
De Meulemeester J, Keymeulen B, De Block C, et al. · Diabetologia · 2025Observational Study, Multicenter Study
- Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes.
Levy CJ, Kanapka L, Brown SA, et al. · Diabetes Technol Ther · 2026Randomized Controlled Trial
Other devices of this type
Also filed under product code LZG.
- Omnipod® Insulin Management System, Omnipod DASH® Insulin Management SystemInsulet Corporation · 510(k) 2021
- Medtronic Minimed Paradigm Insulin PumpsMedtronic Minimed · 510(k) 2012
- Pivot Insulin Delivery SystemModular Medical, Inc. · 510(k) 2026
- Extended ReservoirMedtronic Minimed · 510(k) 2024
- Amigo Insulin PumpNipro Diabetes Systems, Inc. · 510(k) 2007
- Modular Medical MODD1 Insulin Delivery SystemModular Medical, Inc. · 510(k) 2024
- Omnipod GO Insulin Delivery DeviceInsulet Corporation · 510(k) 2023
- Omnipod DASH Insulin Management SystemInsulet Corporation · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.